Durect Corp (DRRX)

1.25
NASDAQ : Health Care
Prev Close 1.27
Day Low/High 1.25 / 1.31
52 Wk Low/High 0.99 / 2.56
Avg Volume 905.00K
Exchange NASDAQ
Shares Outstanding 138.58M
Market Cap 176.00M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies are scooping up shares of their own stock lately.

Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection

Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection

Durect Corp.'s (DRRX) licensee Pain Therapeutics (PTIE) new drug application for an opioid analgesic was denied by the FDA.

5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy

5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy

Here's a technical look at how to trade some of the most active stocks on the market right now.

Interesting DRRX Call Options For April 2017

Interesting DRRX Call Options For April 2017

Investors in Durect Corp saw new options begin trading today, for the April 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

DURECT Provides REMOXY® Update

DURECT Provides REMOXY® Update

Pain Therapeutics Announced today that an FDA Advisory Committee Meeting for REMOXY® is Not Needed and No Change to September 25, 2016 PDUFA Date

DURECT Announces FDA Advisory Committee Meeting For REMOXY®

DURECT Announces FDA Advisory Committee Meeting For REMOXY®

FDA's Tentative Date for Advisory Committee Meeting is August 5, 2016 and No Change to PDUFA Date of September 25, 2016

Insider Trading Alert - SMLP, DRRX And MDSO Traded By Insiders

Insider Trading Alert - SMLP, DRRX And MDSO Traded By Insiders

Stocks with insider trader activity include SMLP, DRRX and MDSO

Insider Trading Alert - DRRX, EA and KAI Traded By Insiders

Insider Trading Alert - DRRX, EA and KAI Traded By Insiders

Stocks with insider trader activity include DRRX, EA and KAI

DURECT Announces Initiation Of DUR-928 Dosing In Patients

DURECT Announces Initiation Of DUR-928 Dosing In Patients

Single-Ascending-Dose Study in NASH Patients

DURECT Announces Positive Phase 1 Data For DUR-928

DURECT Announces Positive Phase 1 Data For DUR-928

Initial Phase 1 Safety Studies Successfully Completed, Positioning for the Start of Patient Studies in 2016